Back to top

Tale of the Tape

Zacks Equity Research

Is A Short Squeeze Ahead for Questcor Pharmaceuticals Inc. (QCOR)?
December 02, 2013

Trades from $3
Many investors appear to be quite bearish Questcor Pharmaceuticals Inc. (QCOR) especially if you look at the percentage of the float that is sold short for this stock. Currently, 26.0% of the float is sold short, suggesting an extreme level of bearishness for QCOR.

However, it is worth noting that earnings estimates have actually been moving higher for the company, despite the pessimism. Thanks to these rising estimates, we actually have a Zacks Rank 1(Strong Buy) on QCOR, so we clearly don’t believe in the negativity surrounding this firm, and are instead looking for shares of QCOR to move higher in the weeks ahead.